Summary
It was the objective of this study to document and evaluate AZT-induced short-term toxicity in healthy individuals. The study was designed as a longitudinal monocentric side-effect monitoring study with prospective data collection. It was carried out at the Cologne University Hospital. The study population comprised health care workers who were taking AZT prophylaxis after accidental exposure to HIV-infected blood. Fourteen individuals were included into the study; seven of them discontinued treatment prematurely, five due to severe subjective symptoms. In case of one worker AZT had to be stopped due to severe neutropenia (800 cells /μl) with signs of upper respiratory tract infection. Four of 11 individuals taking AZT for at least 4 weeks developed neutropenia (2 WHO I, 1 WHO II, 1 WHO III). All other laboratory parameters stayed within normal range. In particular, no anemia was observed. In conclusion: Compared with other studies more neutropenias are observed. Due to side effects 50% of the workers discontinued AZT administration prematurely. The data presented herein show that AZT causes considerable side effects which must be weighed against the potential protective antiviral effect.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Falciano M, Ferri F, Missori R, Massetti AP, Antilici F, Vullo V, Turbessi G (1992) The adverse effects of zidovudine on health care personnel. Int Conf Aids 8:C378 (abstract no. PoC 4813)
Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, King D and the AZT collaborative working group (1987) The efficiacy of 3′-azido-3′ -desoxythymidine (azidothymidine) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial. N Engl. J Med 317:185–191
Mathes LE, Polas PJ, Hayes KA, Swenson CL, Johnson S, Kociba GJ (1992) Pre- and postexposure chemoprophylaxis: evidence that 3′ -azido-3′ -deoxythymidine inhibitis feline leukemia virus disease by a drug-induced vaccine response. Antimicrob Agents Chemother 36:2715–2721
Puro V, Ippolito G, Serafin I, Guzzanti E, Serafin I, Pagano G, Suter F, Cristini G, Arici C, Angarano G, Soscia F, Vaglia A, Bonazzi L and the Italian Study Group Occupational Risk HIV Infection (1992) Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience. AIDS 6:963–969
Puro V, Ippolito G, Serafin I, Guzzanti E and the Italian Study Group Occupational Risk HIV Infection (1993) Update: zidovudine postexposure prophylaxis in Italy. Int Conf AIDS 2:723 (abstract no. Po-C18-3038)
Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, Jackson GG, Durack DT, Phil D, Nusinoff-Lehrmann S and the AZT collaborative working group (1987) The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 317:192–197
Ruprecht RM, O'Brien LG, Rossoni LD, Nusinoff-Lehrmann S (1986) Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidine (letter). Nature 323:467–469
Scadden DT, Zon LI, Groopman JE (1989) Pathophysiology and management of HIV-associated hematological disorders. Blood 74:1455–1463
Shih CC, Kaneshima H, Rabin L, Namikawa R, Sager P, McGowan J, McCune JM (1991) Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type-1 infection in SCID-hu mice in a time-dependant manner. J Infect Dis 163:625–627
Tavares L, Roneker C, Johnston K, Nusinoff-Lehrman S, Noronha F (1987) 3′-Azido-3′-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS. Cancer Res 47:3190–3194
Tokars JI, Marcus R, Culver DH, Schable CA, McKibben PS, Bandea CI, Bell DA the CDC Cooperative Needlestick Surveillance Group (1993) Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 118:913–919
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmitz, S.H., Scheding, S., Voliotis, D. et al. Side effects of AZT prophylaxis after occupational exposure to HIV-infected blood. Ann Hematol 69, 135–138 (1994). https://doi.org/10.1007/BF01695694
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01695694